Drugs / EPC-003
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07193628 | Sep 2025 → Dec 2027 expected | glioblastoma | Second Affiliated Hospital, School of Medicine, Zhejiang University | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EPC-003 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07193628 ↗ |
| Modality | Cell therapy | “CAR-T” NCT07193628 ↗ |
| Route | Other | “intraventricular injection” NCT07193628 ↗ |